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ABSTRACT
Background: Dry needling (DN) has 
been proposed to reduce pain and improve 
function related to myofascial trigger points 
(MTrPs). Several primary studies and sys­
tematic reviews have been conducted to 
examine the effect of DN versus placebo. 
However the comparative effectiveness of 
DN and established interventions has yet to 
be established. Purpose: Ute purpose of this 
systematic review was to determine whether 
DN was more effective than other established 
therapies to treat MTrPs. Data Sources: 
MEDLINE Complete, EBSCO, CINAHL, 
SportDiscus and Cochrane library databases 
were searched. Study Selection: Randomized 
controlled trials that used DN directed to 
MTrPs and used at least one other interven­
tion method were included. Studies that had 
a placebo or sham group were excluded. Data 
Extraction: O f 394 records screened, 8 stud­
ies met the established criteria. The quality 
of each study was assessed using the PEDro 
scale. Data Synthesis: When DN was com­
pared to standard therapy programs, 3 of the 
4 studies found that DN was more effective 
in reducing pain and 1 found no difference. 
When DN was compared to stretching, DN 
reduced pain more effectively. Dry needling 
was not significantly more effective than 
high-power pain threshold ultrasound (US), 
laser, nonsteroidal antiinflammatory drugs, 
and percutaneous electrical nerve stimula­
tion (PENS). Limitations: Included studies 
were relatively small and some lacked sound 
methodology. Conclusions: The results are 
mixed on the effectiveness of DN over stan­
dard rehab. More large scale, high quality 
studies are needed before definitive decisions 
can be made about the role of DN in physical 
therapy practice.
INTRODUCTION
Myofascial trigger points (MTrPs) are pal­
pable,1 hyperirritable1 localized areas of ten­
derness within taut bands of skeletal muscle, 
which may be commonly associated with 
musculoskeletal pain.23 When MTrPs are 
compressed it can lead to local tenderness, 
referred pain2 and can also produce a local 
twitch response (LTR), or muscle fascicula- 
tion.3 There are two main types of MTrPs: 
active and latent. Active MTrPs are active 
without any external elicitation and produce 
both local and referred pain and can lead to 
local muscle weakness.3'4 Active MTrPs are 
the main source of pain, while latent MTrPs 
do not produce symptoms unless externally 
elicited, such as by pressure.’
The exact pathology of MTrPs is 
unknown,5 and their clinical evaluation 
and relevance is still quite controversial.2 
Although the exact physiology of these MTrPs 
is unknown, the underlying cause of MTrPs 
can be from a variety of sources including 
poor muscle balance, poor posture, overuse, 
or a direct injury.6 Because MTrPs are preva­
lent in patients presenting with musculoskel­
etal pain,4 there are a variety of interventions 
that have been established as common prac­
tice including stretching, spray and stretch, 
ultrasound, transcutaneous electrical nerve 
stimulation, laser therapy, injection of local 
anesthetic and dry needling (DN).4,6 Dry 
needling is an technique involving insertion 
of a fine needle into specific MTrPs without 
the use of any medication.4 The use of DN 
is thought to help in the reduction of pain 
derived from MTrPs by providing a localized 
stretch to the shortened sarcomeres.8 This 
helps the sarcomeres to reset to their rest­
ing length thus reducing the taut bands of 
skeletal muscle and reduce the pain related to 
MTrPs.8 It is also thought that DN can help 
with hypoxia by causing an increase in skin 
and muscle blood flow from the needle inser­
tion itself. Dry needling can also help with 
pain reduction by stimulating A-delta nerves, 
which can lead to opioid mediated suppres­
sion of pain.8
A growing body of placebo-controlled 
literature supports the effectiveness of DN 
compared to sham needling. In a systematic 
review by Kietrys et al9 in 2013, the authors 
examined the current literature for studies 
that compared DN to sham or placebo or 
other interventions. Based on the evidence, 
the authors concluded that DN is recom­
mended compared to a sham or placebo 
intervention for the reduction of pain in the 
treatment of upper quarter myofascial pain 
syndrome. Three of the articles the authors 
examined showed positive results in favor 
of DN over sham or placebo for immedi­
ate pain reduction and two of the articles 
examined showed results in favor of DN 
over sham or placebo for reduction in pain 
at 4 weeks postintervention. However com­
parative effectiveness studies are less common 
and no systematic reviews showing only the 
comparative effectiveness literature have been 
published. Although DN may show effec­
tiveness over sham needling in some studies,7 
results are still mixed in this area. Dunning et 
al10 state that several studies that use the in- 
and-out technique of DN have shown some 
benefit in pain relief. However, the authors 
also point out that no high-quality, long­
term studies support the use of DN. Perhaps 
most notably, the comparative effectiveness 
of DN relative to other interventions has 
yet to be summarized. The purpose of this 
systematic review was to assess the meth­
odological quality of the comparative effec­
tiveness literature involving DN in order to 
determine the relative clinical benefit of this 
emerging intervention.
METHOD
Data Sources and Searches
Relevant randomized controlled trials 
were identified by searching MEDLINE 
complete, CINAHL Plus with Full Text, 
and SPORTDiscus with Full Text with the 
search terms DN and randomized controlled
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trials, and DN and the publication type set 
to randomized controlled trials. Articles were 
last searched on October 24, 2014. Abstracts 
were reviewed, and if needed, full text were 
obtained to make decisions about articles 
that fit the above identified inclusion and 
exclusion criteria.
Study Selection
Types o f Studies. Randomized controlled 
trials that used the technique of DN and 
at least one other comparison group were 
included. In addition the articles had to 
describe a study of DN directed to MTrPs. 
Articles were excluded if they were not 
printed in English.
Types o f Participants. The participants in 
the trials had to have an identified area of an 
MTrP in order to be included in this study, 
no restrictions were made based on age or 
gender.
Types o f Interventions. In order to be 
included, the trials must have an included: 
(1) the intervention of DN and (2) another 
type of intervention that was targeted at 
treating these identified MTrP. In addition 
the articles could not use a sham or placebo 
DN.
Types o f Outcomes Measures. Trials were 
used that included a dependent variable mea­
surement involving pain as an outcome mea­
sure, in order to create a basis for uniform 
comparison across studies. Other outcome 
measures used in the articles were taken into 
consideration as well and examined, however, 
the only requirement was to have at least one 
outcome measure that addressed pain.
D ata extraction and assessment
Two authors worked on the article collec­
tion and data extraction. The review was not 
blinded to any of the information including 
the journal, author, or outcome measures. 
The PEDro scale was used to assess the meth­
odological quality of the studies used. Article 
scores were obtained from the PEDro data­
base when available. When no scores were 
available, authors used the PEDro scale to 
rate the article by consensus.
Data synthesis and analysis
No meta-analysis synthesis was used on 
the data collected from these articles. In this 
case, the dependent variable measurements 
were heterogeneous enough among the few 
included studies, and so a narrative litera­
ture synthesis was conducted rather than a 
meta-analysis.
RESULTS
The literature search originally revealed 
394 articles through the databases used and 
through screening and the use of the inclu­
sion and exclusion criteria, 8 articles were 
ultimately deemed appropriate for inclusion 
(Figure 1). These articles examined the effects 
of DN versus various other intervention 
options including manual therapy, stretching, 
high-powered ultrasound (US), non-steroi­
dal anti-inflammatory drugs (NSAIDs), and 
standard rehabilitation therapy. In addition, 
these articles used different outcome mea­
sures that focused on pain, range of motion, 
electromyography (EMG), sleep quality, and 
patient-reported outcomes (Table 1).
O utcom e Measure: Pain
Ziaeifar et al8 compared manual therapy 
MTrP release by a therapist to DN (Table 
2). The outcome measures were taken before 
the treatment sessions and after one week. 
In the DN group, needling was performed 
repeatedly until there were no more LTRs. 
In the manual therapy group, the therapist 
applied gradually increasing pressure to the 
MTrP until the tension and the tenderness 
in the MTrP was released. The results from 
this study showed that both the standard 
intervention group and the experimental 
group significantly improved after interven­
tion when compared to before intervention 
measurements in both the visual analogue 
scale (VAS) and the pressure algometer. In 
addition, there was also a significant between 
group difference in regards to pain intensity 
as measured by the VAS but not in regards 
to the pressure algometer. These results show 
that both the standard intervention and the 
DN significantly reduced pain intensity, 
however, the DN did in fact have more of 
an effect on reducing pain intensity than the 
standard intervention.
In a study done by DiLorenzo et al, 101 
patients were randomized to receive either 
the clinic’s standard rehabilitation therapy 
alone or therapy combined with DN" (see 
Table 2). The outcome measurements were 
taken on day 1 and then again 24 hours 
after every subsequent intervention for the 
DN group. The measurements for the stan­
dard group were taken on day 1 and then 
on days 9, 15, and 21. The results showed 
that VAS scores improved significantly for 
both groups at the first measurement period; 
in addition, there was a significant between 
group difference in favor of DN. For the 
next measurement period, the DN group 
showed significant improvement but the 
standard group did not, and there was a sig­
nificant between group difference in favor of 
DN. For the last group measurement period, 
both groups again showed a significant VAS 
score improvement, and again there was a 
significant between group difference in favor 
of DN. These results would suggest that 
DN was more effective than the standard 
intervention at reducing pain. However, it 
is unclear from the results presented if the 
between group comparisons are in fact for 
the same time period because different data 
recording periods were used for both groups. 
In addition, it is unclear if the significant 
improvement that the DN group made for 
every measurement period was the result 
of comparing the new measurement to the 
baseline or to the previous session’s measure­
ment. While it does appear that DN made 
significant improvements in pain reduction, 
it is difficult to compare these results to the 
standard rehabilitation procedure without 
knowing this additional information.
Bahadir and colleagues12 completed a 
small study (n=20) that randomly assigned 
patients to receive either DN or high-power 
pain threshold ultrasound (HPPTUS; see 
Table 2). Both groups received EMG evalu­
ations. The HPPTUS group therapy was 
repeated two times followed by stretching. 
After the EMG evaluation, the DN group 
had the intervention applied and then 
rested before performing stretching. Both 
groups were instructed to continue stretch­
ing at home. All reported outcome measures 
were taken before the intervention, after a 
30-minute rest, after the intervention was 
performed for the HPPTUS group, 1 hour 
after the original EMG evaluation in the 
DN group, and then again 5 days after the 
original EMG measure. The results from 
this study in regards to pain showed that 
there was a significant decrease in VAS scores 
in the HPPTUS at the initial-immediate 
assessment and the initial-last assessment, 
and there was a significant decrease in the 
DN group at the initial-last assessment but 
not the initial-immediate assessment. These 
results suggest that the HPPTUS was more 
effective than DN in reducing pain in the 
short term (immediately after intervention), 
but not after a delayed amount of time (5 
days postintervention).
Perez-Palomares and colleagues13 con­
ducted a study that randomly assigned 121 
patients with low back pain patients to receive 
either percutaneous electrical nerve stimula­
tion (PENS) to DN (see Table 2). The PENS 
group received 9 treatment sessions and the 
DN group received treatment for 3 sessions. 
The VAS pain and quality of sleep were mea-
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sured at the beginning, before the second 
DN and sixth PENS interventions, and at 
the end of therapy. Algometry and quality 
of life were measured only at the beginning 
and end of intervention. The results found 
that in regards to pain, when the initial VAS 
score was subtracted from the final score 
there was no significant difference between 
the groups. In addition, when algometry dif­
ference was found, again by calculating the 
initial minus the final assessment, there was 
no significant difference between any of the 
body regions measured between the groups. 
These results suggest that there is no differ­
ence in pain results between the therapies of 
PENS and DN, suggesting DN is no more 
effective than PENS. However, it is possible 
that the PENS could in essence act in a some­
what similar fashion to DN as the needle is 
inserted below the skin in order to apply the 
electrical current. This insertion of the needle 
could potentially serve the same purpose as 
when the needle is inserted in the technique 
of DN.
Eroglu et al5 also conducted a study of 
60 subjects that examined DN, compar­
ing it to oral flurbiprofen and lidocaine 
injection (Table 2). Measurements for VAS 
pain, algometry, neck range of motion and 
patient-reported outcomes were taken pr- 
intervention and on the third and fourteenth 
days of intervention. The patients in the oral 
flurbiprofen group were given 100 mg tablets 
2 times per day for 7 days. The patients in 
the lidocaine group and DN were given the 
same needling procedure except the lidocaine 
group also received an injection of 0.2 ml of 
2% lidocaine solution through the needle. In 
addition, all of the patients were given a home 
exercise program (HEP) and instructed to 
follow it. The authors5 found that all groups 
showed significant improvement in algome­
try and VAS pain, and in addition, there was 
no significant between group differences for 
any of the outcome measures. These results 
show that DN was no more effective than 
oral flurbiprofen or lidocaine injection in 
reducing pain associated with MTrPs.
A study by Ilbuldu et al14 compared the 
effectiveness of DN to that of laser and pla­
cebo laser. In this study, 60 patients were ran­
domized into DN, laser, or the placebo laser 
group (Table 2). The DN group received 4 
intervention sessions, and the laser group 
received treatment for 12 sessions. The pla­
cebo group received probe intervention with 
the machine turned on and set but no beam 
applied. In addition all the groups received 
instruction in stretching and were required 
to exercise regularly. Patients were also given
paracetamol tablets as needed for pain and the 
number of tablets used throughout the study 
was recorded. Outcome measures included 
VAS pain scale, algometry, cervical ROM, and 
the Nottingham health profile. Measurements 
were taken preintervention, postintervention 
(4 weeks), and at a 6-month follow-up. The 
results for pain showed that the VAS pain for 
rest and activity decreased in all groups pos- 
tintervention and at the 6-month follow-up. 
In addition, there was a significant between 
group difference in favor of the laser group 
at the postintervention measurement for VAS 
rest and activity but this disappeared at the 
6-month follow-up. In regards to algometry, 
there was a significant between group dif­
ference in favor of the laser group for pain 
threshold at the postintervention measure but 
again this disappeared at the 6-month follow­
up. There was no difference for pain toler­
ance between any of the groups. The analgesic 
usage was also shown to be significantly less 
in the laser group postintervention, but again, 
not at the 6-month follow-up. These results 
suggest that laser is more effective than DN at 
reducing many aspects of pain postinterven­
tion in the short term but not in the long term 
(6-month follow-up).
Rayegani et al15 conducted a study where 
28 subjects were randomly assigned to receive 
either DN or physiotherapy (see Table 2). 
The DN group consisted of a session of nee­
dling, and afterwards patients were advised to 
apply ice and Capsaicin cream. The physio­
therapy group had 10 sequential sessions of 
therapy that included superficial heat, TENS, 
US, and upper trapezius (UT) stretching by 
a therapist. In addition, both groups were 
instructed to stretch daily for a month. Out­
come measures, VAS pain, algometry, and the 
SF-36 questionnaire, were taken preinter­
vention and one week and one month after 
the last intervention session. The results in 
regards to pain showed that at the one week 
follow-up there was significant reduction in 
rest, night and activity pain in both the phys­
iotherapy and DN groups. In addition, there 
was a significant increase in pain pressure 
threshold as measured through algometry in 
both groups as well. There were no signifi­
cant differences between groups. At the one 
month follow-up, there was again a signifi­
cant reduction in activity, rest and night pain; 
a significant increase in pain pressure thresh­
old in both groups; and there was no signifi­
cant difference between groups. These results 
show that while both interventions are effec­
tive in reducing pain in subjects with myo­
fascial pain syndrome, there is no difference 
between DN and physiotherapy in regards to
pain reduction; thus DN is no more effective 
than physiotherapy in reducing pain.
A study by Edwards et al,is randomly 
assigned 40 patients into 3 groups of 13 or 
14 subjects to receive either DN and active 
stretching, stretching alone, or no interven­
tion (Table 2). The outcome measures (the 
Short Form McGill Pain Questionnaire 
(SFMPQ) and algometry) were measured 
preintervention, after 3 weeks, then 6 weeks 
from the commencement of intervention. 
Participants in the DN group received a 
varying number of DN sessions. After nee­
dling, stretching was performed and patients 
were instructed to continue these stretches at 
home. The patients in the stretching group 
received instruction in stretching exercises 
and were instructed to continue these at 
home. The results showed that there was 
no significant difference between groups at 
the 3-week measurement. However, at the 
6-week measurement, the DN and stretching 
group showed significantly improved scores 
on the SFMPQ compared to the no interven­
tion group and significantly improved pain 
pressure threshold compared to the stretching 
alone group. These results suggest that DN is 
more effective than stretching alone at reduc­
ing pain pressure threshold; however, the fact 
that there is no significant difference in the 
SFMPQ suggests that DN has a limited role 
in reducing pain over stretching alone.
O utcom e M easure: E lectrom yography
In 20 subjects, Bahadir et al12 compared 
DN to HPPTUS. This was the only study 
reviewed that used EMG activity as an out­
come measure (see Table 2). The number of 
LTRs in the HPPTUS group decreased sig­
nificantly both from initial EMG measure­
ment (taken before intervention), immediate 
EMG measurement (taken after the inter­
vention on the same day), and final EMG 
measurement (taken on the fifth day). The 
number of recordings of spontaneous elec­
trical activity (SEAs) decreased significantly 
from the initial to immediate assessment but 
not from the initial to the final assessment. 
In the DN group, the number of LTRs and 
SEAs did not decrease significantly from the 
initial to the immediate assessment or from 
the initial to the final assessment. While the 
HPPTUS group did experience a more sig­
nificant reduction in LTRs and SEAs than 
the DN group, it is possible that the EMG 
needle insertion itself may have had a simi­
lar effect to DN. In addition, the number of 
sessions of HPPTUS carried out was greater 
than that of DN, which could also account 
for this discrepancy.
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Table 2. Summary of Findings for Included Studies
Study Type o f Study
Evidence
Rating C onditions Sample Characteristics
Ziaeifar, Arab, 
K arim i, &  
N ourbakhsh8
R andom ized 
C ontro lled  Trial
4 /10 3 tim es/w eek for 1 week, for bo th  the 
trea tm en t (T C T ) and  the experim ental 
g roup (D ry  N eedling  or D N ).
33 patients w ith  myofascial trigger po in t 
M TrP in the upper trapezius (U T) muscle. 
In tervention  group: 17 participants m ean 
age 26 .5  ± 8.57, m ean w eight 56 +
5.92 kg, m ean height 163.7 ± 4.49 cm. 
Experim ental group: 16 participants, mean 
age 30 .06  ± 9.87, m ean w eight 60 .37  ± 
6 .96  kg, m ean height 165.3 + 7 .56  cm.
D iLorenzo, Traballesi, 
M orelli, Pom pa, 
Brunelli, Buzzi, & 
Form isano"
R andom ized 
C ontro lled  Trial
6 /10 Both D N  and standard  rehabilita tion 
groups, received standard  rehabilita tion 
therapy. The D N  group received 4 
sessions o f  D N , each 5-7 days apart.
101 patients tha t were post-cerebrovascular 
accident (CVA) and were experiencing 
shoulder pain on the hem i-paretic side due 
to MTrP, 54 patients in D N  group and  47 
patients in contro l group. M ean age D N  
group 69.56 ± 6.21, contro l group 67.43 
± 9.05. G ender males: females D N  group 
14:40, contro l group 14:33. Post stroke 
m ean duration  (weeks) D N  group 3.50, 
control group 3.57.
Bahadir, Majlesi, 
&  U nalan i:l
R andom ized 
C ontro lled  Trial
2 /10 3 consecutive days for the H igh- 
pow ered pain threshold  u ltrasound 
(H P PT U S ) group and then  hom e 
stretching exercises for 2 consecutive 
days, and  1 trea tm en t and  4 
consecutive days o f  hom e stretching 
exercises for the  D N  group.
23 female patients w ith  M T rP  in the U T  
m uscle (3 participants dropped  o u t so only 
20 finished the study).
Rayegani, Bayat, 
B ahram i, Raeissadat, 
&  K argozar15
R andom ized 
C ontro lled  Trial
4 /10 D N  group consisted o f  1 session 
follow ed by 1 m on th  o f  hom e 
stretching program . Physiotherapy 
group consisted o f  10 sequential 
sessions o f  superficial heat, 
T ranscutaneous Electrical N erve 
S tim ula tion  (TEN S) U ltrasound  (US), 
U T  stretching by a therapist and  1 
m o n th  o f  hom e stretching program .
28 participants w ith M TrP in the U T  
muscle. D N  group 14 participants, m ean 
age 32 ± 10. Physiotherapy group 14 
participants, m ean age 38 .6  ± 4.2
Ilbuldu, C akm ak, 
Disci, &  A ydin14
R andom ized 
C ontro lled  Trial
6 /1 0 3 Laser sessions/week for 4  weeks and 
hom e stretching program  for Laser 
group. 3-placebo Laser sessions/week 
for 4 weeks and  hom e stretching 
program  for placebo group. 1 session/ 
week for 4 weeks and  hom e stretching 
program  for d ry  needling group.
60 females betw een the age o f  18-50 w ith 
M TrP in U T  muscle, m ean age placebo 
group 32.35 ± 6.88, D N  35.29 ± 9 .1 8 , 
Laser 33 .90  ± 10.36
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O u tcom e M easures Im portant Results
Pain intensity: Visual A nalog Scale 
(VAS), Pain Pressure Threshold 
(PPT ), D isability  o f  the  A rm , 
Shoulder and H a n d  (D A SH ) 
questionnaire
There was a significant difference from  p re trea tm en t to p osttrea tm en t for VAS, PPT, &  D A SH  for bo th  T C T  (P 
= 0 .000, 0 .001, &  0 .006  respectively) &  D N  (P = 0 .000, 0 .000 , &  0.001 respectively). In  add ition  there was a 
significant difference betw een D N  & T C T  group posttrea tm ent for the VAS (P = 0.01) b u t n o t for P P T  or D A SH .
Pain (VAS), du ra tio n  o f  
hospitalization , F unctional M obility  
(R iverm ead M obility  Index), Sleep 
Q uestionnaire  to address daytim e 
rest &  sleep quality
H°= baseline VAS scores. H 1, H* and H 3 = subsequent VAS assessments. VAS pain scale decreased significantly 
for the  D N  group from  entry  th ro u g h o u t each successive m easurem ent, P-values H 1 <0.001, H* 0 .005 , H 3 0.05; 
however for the standard  rehabilita tion  group the VAS scores were significant for H 1 and  H 3 bo th  w ith  a P = 0.05, 
b u t H" d id n o t have a significant reduction  w ith  a P = 0.25. In add ition  there was a significant betw een group 
difference for each tim e period, H 1 P <0.001, H* P <0.001, and  H 3 P <0.001. Sleep questionnaire reported  th a t 
the D N  group had 85 .19%  o f  the participants responds yes to question 1 (did you rest well in w heelchair or bed 
during  the last 2 weeks?) and  68 .08%  o f  the standard rehabilita tion  group responded yes as well, w ith  a P = 0.034. 
In  add ition  92 .59%  o f  the  D N  group and  74 .47%  o f  the standard  rehabilita tion  g roup responded yes to question 
2 (d id  you sleep well du ring  the last 7 nights?) w ith  a P = 0 .039. R M I effectiveness [100 x (discharge scale score 
-  initial scale score)/(m axim um  scale score -  initial scale score)] for D N  group was 50 .01%  ± 15.38%  and for 
standard  rehabilita tion  was 47 .54%  ± 17.34% .
Pain (VAS), E lectrom yography 
(E M G ), Range o f  M otion  (R O M ), 
(Active R O M  lateral flexion)
There was a significant decrease in VAS for H P P T U S  from  initial to im m ediate assessment and initial to last 
assessment (P = 0 .007 &  0.005). For the D N  group there was only a significant decrease from  the initial to last 
assessm ent b u t n o t the  initial to im m ediate assessment (P = 0 .007  &  0.785). There was a significant im provem ent 
in R O M  for H P P T U S  from  initial to im m ediate and initial to last assessment (P = 0.011 &  0.007). However, 
for the D N  group there was only a significant decrease from  the initial to last assessm ent b u t n o t the initial to 
im m ediate  assessm ent (P = 0 .005 &  0 .783). There was a significant difference for LTR from  initial to im m ediate 
and  initial to last assessm ent for H P P T U S  (P = 0 .009 &  0 .015), b u t none for the D N  (P = 0 .160 &  0.129). There 
was a significant difference only for initial to im m ediate assessment for H P P T U S  n o t the initial to last (P = 0 .016 
&  0.123) and none for D N  (P = 0 .109 &  0.564). In  add ition  there was a significant betw een group difference in 
favor o f  the H P P T U S  for VAS (P = 0 .009) and  n u m b er o f  LTRs (P = 0.015) b u t n o t for R O M  (P = 0 .136) or 
nu m b er o fSE A s (P = 0.123)
Pain (VAS &  algom eter), Q uality  o f 
life (SF-36)
There was a significant reduction in rest, n ight, &  activity pain in the  physiotherapy and  D N  group at the 1 week 
follow -up, as well as significant increase in PPT. For the SF-36 scale at 1 week in the physiotherapy group there was 
significant im provem ent in social functioning, role lim ita tion  due to  physical problem s and  physical function ing  (P 
<0.05) b u t no significant changes in vitality, role lim ita tion  due to em otional problem s, general health , and  m ental 
health . For the D N  group no significant changes were observed in the SF-36 scale. A t 1 m on th  follow -up bo th  
groups had significant decrease in activity, rest and  n ight pain  and  significant increase in PPT, bodily pain, physical 
function ing , role lim ita tion  due to physical problem s and social function ing  (P <0.05. There were no significant 
betw een group differences for any o f  the outcom es (P >0.1).
Pain In tensity  (VAS, analgesic usage, 
algom eter), Cervical R O M  (Flexion, 
extension, bilateral ro ta tion , bilateral 
lateral flexion), Functional status 
(N o ttingham  H ealth  Profile)
Decrease in rest an d  activity subgroups o f  VAS at posttreatm ent. Significant decrease VAS rest (P < 0 .05) and  
activity (P = 0.001) in laser group com pared to D N  and placebo groups a t posttrea tm ent, b u t th is disappeared at 
the 6 m o n th  follow -up. Significant increase in pain threshold  in laser com pared to D N  and  placebo (P < 0 .001) 
a t the posttreatm ent, b u t again this disappeared at the 6 -m o n th  follow -up. Significant difference in analgesics 
used, fewer in laser g roup (P < 0.05) at post treatm ent, b u t n o t at 6 -m o n th  follow -up (P > 0 .05). Significant 
increase in flexion at p o sttrea tm en t in D N  &  laser groups, b u t no difference at the 6 -m o n th  follow -up (P >0.05). 
Significant increase in extension in laser group com pared to D N  and placebo group (P < 0 .001), b u t no difference 
at the  6 -m o n th  follow -up (P > 0 .05). There were no differences in ro tation . Significant difference in right and  left 
lateral flexion in laser group com pared to D N  and  placebo group (P < 0.001 &  < 0.01) at post trea tm ent, b u t no t 
at 6 -m o n th  follow -up. For the N o ttingham  H ealth  Profile, there was a significant difference in  pain  and  physical 
activity subgroups a t p osttrea tm en t (P < 0.001 &  < 0.05) for laser com pared to D N  and  placebo groups, b u t this 
disappeared at the 6 -m o n th  follow -up. There were no o ther significant differences in any o f  the subgroups in the 
N o ttingham  H ealth  Profile.
(Continued on page 184)
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Table 2. Summary of Findings for Included Studies (Continued from  page 183)
Study Type o f Study
Evidence
Rating C onditions Sample Characteristics
Edwards & Knowles16 Randomized 
Controlled Trial
6/10 DN group received a stretching 
home exercise program (HEP) and a 
varied amount of DN sessions over a 
3-week period depending on patient 
condition and convenience of patient 
and therapist (mean number treatment 
sessions 4.6). Stretching group received 
a HEP in stretching and performed 
this program for 3 weeks and received 
follow up sessions to check up on 
stretching form (mean number 
treatment session 2.9). In addition 
the DN and stretching group received 
instruction in posture. After the 3 
weeks of intervention, both groups had 
a 3-week period of no intervention. The 
control group received no treatment.
40 subjects aged 18 and over and with 
identifiable MTrP. Mean age DN group 57 






7/10 All groups received instruction in 
a stretching HEP. The DN group 
received 1 session of DN, the LI 
group received needling and injection 
of lidocaine, and the OF group 
received 2xl00mg/day tablets of oral 
flurbiprofen for 7 days.
60 patients, 7 males & 53 females. Mean 
age DN group 33.75 ± 8.10, LI group 











5/10 Percutaneous Electrical Nerve 
Stimulation (PENS) group received 9 
sessions, 3 sessions (lasting 30 minutes) 
per week on alternate days for 3 weeks. 
DN group received 3 sessions, 1 per 
week with at least an 8-day latent 
period between sessions, for 3 weeks. 
Each session was followed by the spray 
and stretch technique, where each 
muscle was passively stretched in 3 
sequences and vapocoolant spray was 
applied to the pain reference zone in 3 
sweeps for each sequence.
122 patients, 91 females & 31 males.
PENS group and DN group percentages: 
gender male 18.8% & 32.8% respectively, 
female 81.3% & 67.2% respectively 
(P-value 0.08); age less than 40 34.4% & 
50.0% respectively, 40-60 45.3% & 31.0% 
respectively, greater than 60 20.3 % &
19.0& respectively (P-value 0.18).
Outcome Measure: Range o f Motion
Three studies examined ROM as an out­
come measure (see Table 2). Bahadir and 
colleagues12 examined ROM in the cervical 
region in a group of 20 subjects. The results 
from this study11 show that the HPPTUS 
group had significant improvement in ROM 
from preintervention to immediately pos­
tintervention, but the D N  group did not. 
In addition, both groups showed significant 
improvement in ROM from initial interven­
tion to 5 days postintervention. These results
suggest that both interventions can be helpful 
in increasing ROM in cervical lateral flexion 
after an extended period (5 days), but only 
HPPTUS shows immediate improvements. 
However, both of these groups underwent an 
EMG evaluation that involved needle inser­
tion, which could in essence behave like DN.
Eroglu et al5 also conducted a study with 
60 subjects using ROM as an outcome mea­
sure. The results from this study showed 
that the neck ROM for lateral flexion and 
rotation increased significantly on the third
and fourteenth days in all groups, regard­
less of intervention. In addition the authors 
found there was no between group differ­
ence.5 These results suggest that D N  is no 
more effective than the previously established 
interventions of NSAIDs (oral flurbiprofen) 
or lidocaine injection.
One other study that met the search cri­
teria was included for review. This study was 
done by Ilbuldu et al14 where the effective­
ness o f D N  was compared to that o f laser and 
placebo laser. The results showed that there
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O utcom e Measures Im p o rtan t Results
Pain: Short- Form McGill Pain 
Questionnaire (SFMPQ), PPT- 
algometer)
No significant difference between groups at 3 weeks after trial started. At 6 weeks after trial started, the DN group 
was significantly different compared to the control group in SFMPQ (P = 0.043), and was significantly different 
compared to the stretch group in PPT scores (P = 0.011). There was a significant difference in PPT and SFMPQ in 
the DN group.
Pain (VAS), Quality of Life Scale 
(Nottingham Health Profile 
[NHP]), ROM (AROM neck:
flexion, extension, bilateral lateral 
flexion, bilateral rotation/ shoulder: 
abduction, adduction, flexion, 
extension, 1R, ER)
Treatment: Algometric Sensitivity F„ 0.58, P-value 0.55, VAS-pain score F„ 2.073, P-value 0.13, Lateral Flexion 
right Fn 0.854, P = 0.42, Lateral Flexion left F„ 1.29, P = 0.27,Roation right F„ 2.174, P = 0.11, Rotation left 
F„ 1.92, P = 0.14. Time: Algometric Sensitivity F„ 108.28, P <0.001, VAS-pain score F„ 73.97, P<0.001, Lateral 
Flexion right Fn 38.74, P <0.001, Lateral Flexion left F„ 26.83, P-value <0.001, Rotation right F„ 23.76, P 
<000.1, Rotation left F„ 17.30, P <0.001. Interaction: Algometric Sensitivity F„ 1.22, P = 0.29, VAS-pain score 
F„ 0.41, P = 0.76, Lateral Flexion right F„ 0.685, P = 0.56, Lateral Flexion left F„ 0.55, P-value 0.67, Rotation 
right F„ 0.40, P = 0.79, Rotation left F„ 0.70, P = 0.56. Nottingham Health Profile: Treatment: NHP-pain F„ 
0.67, P = 0.49, NHP-physical activity F„ 0.02, P = 0.97, NHP-fadgue F„ 1.13, P = 0.32, NHP-sleep F , 1.91, P 
= 0.14, NHP-social isolation F„ 1.76, P = 0.30, NHP-entotional reactions F„ 0.83, P = 0.42. Time: NHP-pain 
F„ 53-79, P <0.001, NHP-physical activity F„ 27.00, P <0.001, NHP-fatigue F„ 34.10, P <0.001, NHP-sleep 
F„ 38.23, P <0.001, NHP-social isolation F„ 5.99, P = 0.002, NHP-emotional reactions F„ 39.35, P<0.001. 
Interaction: NHP-pain F„ 0.17, P = 0.93, NHP-physical activity Fn 0.73, P = 0.56, NHP-fatigue F„ 3.06, P = 
0.02, NHP-sleep F„ 1.78, P = 0.13, NHP-social isolation F„ 1.33, P = 0.25, NHP-emotional reactions F„ 1.38, P
= 0.23.
Pain (VAS, PPT-algometer), Quality 
of Life Scale (Oswestry Disability 
Index), & Sleep Quality (VAS)
PENS & DN groups VAS pain (Initial-final): 2.38 (±2.27) & 2.35 (±2.58) respectively (P = 0.94); VAS sleep 
quality (Initial-final): 1.72 (±2.67) & 1.85 (±2.66) respectively (P = 0.68). PENS & DN groups PPT (Initial-final): 
right deep paraspinals 0.91 (±4.39) & 1.04 (±4.45) respectively (P = 0.93); left deep paraspinals 1.75 (±4.6) & 2.06 
(±3.35) respectively (P = 0.83); right quadrants lumborum 0.89 (±3.10) & 1.73 (±3.47) respectively (P = 0.33); 
left quadratus lumborum 0.76 (±2.77) & 1.64 (±2.91) respectively (P = 0.12); right gluteus medius 0.77 (±3.27) & 
0.87 (±2.76) respectively (P = 0.32); left gluteus medius 058 (±2.46) & 1.77 (±3.44) respectively (P = 0.14). PENS 
& DN group Oswestry Disability Index (Initial-final): personal care 0.38 (±0.97) & 0.34 (±0.82) respectively (P 
= 0.94); lifting weight 0.59 (±1.42) & 0.06 (±0.96) respectively (P = 0.03); walking 0.17 (±0.98) & 0.15 (±0.57) 
respectively (P = 0.86); sitting 0.21 (±0.89) & 0.33 (±1.05) respectively (P = 0.51); standing 0.25 (±0.84) & 0.41 
(±0.82) respectively (P = 0.26); social life 0.72 (±1.10) & 0.72 (±3.03) respectively (P = 0.178). Number of patient 
with more than 40% reduction in VAS pain: PENS 28 (53.85%) & DN 24 (46.15%).
was a significant increase in flexion at pos­
tintervention in the DN and laser groups, 
but this disappeared at the 6-month follow­
up. In addition, ROM for extension was 
significantly increased compared to the DN 
and placebo groups at postintervention mea­
surement, but again this disappeared at the 
6-month follow-up. There was no significant 
difference in rotation for any of the groups or 
follow-ups. In regards to lateral flexion, both 
left and right were increased in laser group 
compared to the DN and placebo groups at
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4 weeks but at 6 months there was no differ­
ence. These results would suggest that laser 
was more effective than DN to help increase 
cervical ROM in the short term, but there 
was no difference between the two interven­
tions in the long term (6 months).
O utcom e Measure: Q uality  o f  Sleep
Two studies examined the quality of sleep 
as an outcome measure (see Table 2). In the 
study by Perez-Palomares and colleagues13 
where PENS was compared to DN in 121
185
subjects with low back pain, a VAS scale was 
used to identify quality of sleep. The final 
score was subtracted from the initial score 
and compared across groups; there was no 
significant difference between the PENS 
group and the DN group. This would sug­
gest there is no benefit of DN over PENS in 
regards to sleep quality.
Another study by DiLorenzo et al11 also 
examined quality of sleep using a sleep ques­
tionnaire that consisted of 2 questions. These 
questions were answered only at the last visit
with a yes or a no response. The authors11 
found that 85.2% of the DN group felt that 
they rested well in the wheelchair or bed 
during the last 2 weeks (question 1) com­
pared to 68.1% of the standard rehabilitation 
group, which was a significant between group 
difference. In addition there was also a signif­
icant between group difference for question 
2 which asked the question, “Did you sleep 
well during the last 7 nights?” For this ques­
tion, 92.6% of the DN group answered “yes” 
whereas only 74.5% of the standard reha­
bilitation group answered “yes.” These results 
would suggest that the addition of DN to 
the standard rehabilitation program did have 
positive effects that helped the patients to 
sleep better.
Outcome Measure: Patient-reported 
Outcomes
Perez-Palomares and colleagues13 also 
examined patient-reported outcomes in their 
study that compared PENS to DN (see Table 
2). The authors13 used the Oswestry Disability 
Index. As with their other outcome measure 
comparisons, the final measurements were 
subtracted from the initial measurements. In 
the subcategories of personal care, walking, 
sitting, standing, and social life, there was no 
significant difference found between groups. 
However, in the area of lifting weight, there 
was significant difference in favor of the DN 
group. This would suggest there is a slight 
benefit of DN over PENS in quality of life, 
specifically in the lifting weight subcategory 
of the Oswestry Disability Index.
In the study by Eroglu et al,’ the authors 
used the Nottingham Health Profile, which 
included the subcategories of pain, physical 
ability, fatigue, sleep, social isolation, and 
emotional reactions, as a measure of quality 
of life (see Table 2). The authors found that 
all groups showed a significant improvement 
in the quality of life measure in all subcat­
egories. When between group comparisons 
were made, it was found that the only sig­
nificant difference was for the subcategory of 
fatigue on the third and fourteenth day mea­
surements. This difference was found for the 
lidocaine group, and since this is not an inter­
vention that physical therapists can admin­
ister, which is the focus of this paper, the 
difference was not considered. These results 
suggest that in terms of quality of life, DN is 
no more effective than oral flurbiprofen.
Ziaeifar et al8 also used a patient-reported 
outcome measure in their study. In this case 
they used the DASH (Disability of Arm, 
Hand, and Shoulder; see Table 2). The 
authors found that there was a significant
change in DASH scores from preinterven­
tion to postintervention in both groups. 
There was no significant difference between 
groups, suggesting that DN has no greater 
benefit than MTrP compression therapy in 
regards to aspects of quality of life measured 
by the DASH.
DiLorenzo et al11 examined patient- 
reported outcomes through the use of the 
Rivermead Mobility Index (RMI; see Table 
2). The authors11 calculated the effectiveness 
of RMI through the use of the equation [100 
x (discharge scale score -  initial scale score)/ 
(maximum scale score -  initial scale score)]. 
The authors11 did not comment on the signif­
icance of the different values calculated, only 
that the effectiveness was 50.0% for the DN 
group and 47.5% for the standard rehabilita­
tion group. From this it appears that there 
was no significant difference between the 
groups and thus DN was no more effective 
than the standard rehabilitation intervention.
The study by Ilbuldu et al14 examined the 
effectiveness of DN compared to that of laser 
and placebo laser (see Table 2). The patient- 
reported outcome used was the Nottingham 
Health Profile. In the subcategories of pain 
and physical activity, a significant difference 
was noted postintervention in favor of the 
laser group over the placebo laser and the DN 
groups. However, this difference disappeared 
at the 6-month follow-up. In addition, for 
the subcategories of fatigue, sleep, social iso­
lation, and emotional reaction there were no 
significant differences at postintervention or 
the 6-month follow-up. These results would 
suggest that the laser was more effective in 
helping to reduce pain and increase physical 
activity in the short term but not the long 
term, which coincides with the results from 
the outcome measures that the authors used 
to address pain including analgesic usage, 
VAS pain scale, and algometry.
Rayegani et al15 used the SF-36 in their 
study as the measure of patient-reported 
outcomes (see Table 2). The results showed 
that there was significant improvement in 
the subcategories of social functioning, role 
limitation due to physical problems, and 
physical functioning in the physiotherapy 
group. However, in this same group, no sig­
nificant improvement was found in the sub­
categories of vitality, role limitation due to 
emotional problems, or general and mental 
health. In contrast, the DN group showed no 
changes in any of these subcategories. There 
were no significant differences between the 
groups. At the 1 -month follow-up, there was 
a significant increase in bodily pain, physi­
cal functioning, role limitation due to physi­
cal problems, and social functioning in both 
groups with no significant difference between 
groups. These results show that DN is not 
more effective at improving quality of life in 
the short term as measured by the SF-36 and 
in some areas, physical therapy may even be 
more effective.
DISCUSSION
This systematic review was undertaken 
to summarize the relative effect of DN com­
pared to other interventions that physical 
therapists may use to treat symptoms and 
disablement related to MTrPs. Dependent 
variable measurements of the included stud­
ies were pain, EMG activity, ROM, sleep 
quality, and quality of life. In regards to the 
outcome measure of pain, there were only 
3 studies that showed that DN was better 
than the intervention to which it was com­
pared.8,11,16 However, notably, DN was more 
effective in 3 of the 4 studies that examined 
manual therapy interventions.8,11,15,16 How­
ever, when compared to other modalities, 
DN was no more or less effective in reducing 
pain in all 4 of the studies examined.
In regards to ROM measurement and 
EMG activity (specifically reduction of 
LTRs), DN was not found to be more effec­
tive in any of the studies. When examining 
sleep and quality of life, the results of the 
studies are again somewhat mixed but most 
favor the result of DN being no more or less 
effective than other interventions.
Considering all results it appears that 
DN by far has the greatest effect on pain 
reduction. It is still unclear if DN is more 
effective than other common interventions 
used. However it does appear that DN is 
more effective in reducing pain over manual 
therapy. This would support the argument 
for the use of DN in the clinic as a method 
for pain reduction. Lastly it is important 
to note that these studies were of relatively 
small size and had varying levels of quality in 
regards to their methodologies, with PEDro 
scores ranging from 2/10 to 7/10. Thus, it is 
important for more research to be conducted 
in this area, specifically a high quality, large 
scale study that compares DN to a standard 
rehabilitation intervention.
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